These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4135417)

  • 21. Loss of transplantation antigen in primary simian virus 40-induced tumors and their metastases.
    Deichman GI; Kluchareva TE
    J Natl Cancer Inst; 1966 Apr; 36(4):647-55. PubMed ID: 4286936
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
    Ting CC; Rogers MJ
    Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 24. Antilymphoma graft responses in the mouse brain: a study of T-dependent functions.
    Puccetti P; Giampietri A; Campanile F; Romani L; Fioretti MC
    Int J Cancer; 1983 Jun; 31(6):769-74. PubMed ID: 6602778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of cancer immunology.
    Ritts RE; Neel HB
    Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: HL-A antigens in lymphatic leukaemia.
    Davey FR; Henry JB; Gottlieb AJ
    Lancet; 1973 Oct; 2(7832):802. PubMed ID: 4126512
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenic properties of solubilized tumour antigen from an RNA virus-transformed neoplasm.
    Law LW; Apella E
    Nature; 1973 May; 243(5402):83-7. PubMed ID: 4122415
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incorporation of SV40-tumor specific transplantation antigen (SV40-TSTA) in vesicular stomatitis virus grown in SV40 transformed hamster cells (author's transl)].
    Ansel S
    Int J Cancer; 1974 Jun; 13(6):773-84. PubMed ID: 4368160
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of ability of defective foreign genomes (PARA and MAC) carried by human adenoviruses to induce SV40 transplantation immunity.
    Rapp F; Butel JS; Tevethia SS; Melnick JL
    J Immunol; 1967 Aug; 99(2):386-91. PubMed ID: 4291652
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential expression of class I major histocompatibility complex determinants by lymphoblastic leukemia-lymphoma cell lines.
    Hester RB; Rohrer SD; Liu PI; Coggin JH
    J Natl Cancer Inst; 1990 Jul; 82(14):1209-14. PubMed ID: 1694547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and interruption of SV40 induced transplantation immunity with tumor cell extracts.
    Tevethia SS; Rapp F
    Proc Soc Exp Biol Med; 1966 Nov; 123(2):612-5. PubMed ID: 4288641
    [No Abstract]   [Full Text] [Related]  

  • 32. Development in hamsters of antibodies against surface antigens present in cells transformed by papovavirus SV40.
    Tevethia SS; Couvillionla ; Rapp F
    J Immunol; 1968 Feb; 100(2):358-62. PubMed ID: 4295750
    [No Abstract]   [Full Text] [Related]  

  • 33. Significance of specific transplantation antigen expression at the surface of papovavirus SV40-infected permissive cells.
    Tevethia SS; Tevethia MJ
    Bibl Haematol; 1975 Oct; (43):74-7. PubMed ID: 183734
    [No Abstract]   [Full Text] [Related]  

  • 34. Specificity of the Tumor-specific transplantation antigen induced by JC virus, a human polyomavirus.
    Padgett BL; Hunt JM; Walker DL
    Intervirology; 1977; 8(3):182-5. PubMed ID: 67106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histocompatibility antigens on murine tumors.
    Goodenow RS; Vogel JM; Linsk RL
    Science; 1985 Nov; 230(4727):777-83. PubMed ID: 2997918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotherapy of malignant disease.
    Wright PW; Hellström KE; Hellström IE; Bernstein ID
    Med Clin North Am; 1976 May; 60(3):607-22. PubMed ID: 946896
    [No Abstract]   [Full Text] [Related]  

  • 38. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of SV40 virus oncogenesis in hamsters. II. The effect of thymectomy on induction of tumor resistance by SV40-transformed human cells.
    Girardi AJ; Roosa RA
    J Immunol; 1967 Dec; 99(6):1217-20. PubMed ID: 4294651
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody patterns to Herpesvirus saimiri-induced antigens in owl monkeys.
    Pearson GR; Orr T; Rabin H; Cicmanec J; Ablashi D; Armstrong G
    J Natl Cancer Inst; 1973 Dec; 51(6):1939-43. PubMed ID: 4358150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.